Amplification or epigenetic modification of TERT (rs7734992, 5p15.33) plays a crucial role in ccRCC by maintaining cellular immortality, with HIF1A and EPAS1 regulating TERT expression, enhancing tumour survival under hypoxic conditions45. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.